- October 24, 2025 - Rose Pharma Inc., a clinical-stage biopharmaceutical company developing ROSE-010, a rapid-onset, short-duration GLP-1 therapy targeting both weight management and acute IBS pain, today announced that Chief Executive Officer Enda Kenny, PhD will present data from its recent clinical trial in weight management at #ObesityWeek2025 (sponsored by The Obesity Society) on Tuesday, November 4, 2025 at 7:30 p.m
doi: 10.1016/j.aqrep.2023.101585 39 ChenX.LiP.HouD.LiM.ChenB.PengK.et al
Dermatol Clin, 6: 105-114
- Consultar con un mdico antes de usar si ests embarazada, en perodo de lactancia, tomando algn medicamento o tienes alguna condicin mdica preexistente
Like any medical treatment, lipotropic injections carry potential risks, and they are not appropriate for everyone
Understanding your result gives you a personalized starting point for a targeted lifestyle and nutrition strategy grounded in your unique genetic biology